Impact of upfront cellular enrichment by laser capture microdissection on protein and phosphoprotein drug target signaling activation measurements in human lung cancer: Implications for personalized medicine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Impact of upfront cellular enrichment by laser capture microdissection on protein and phosphoprotein drug target signaling activation measurements in human lung cancer: Implications for personalized medicine

Published:2015-03-24 Issue:9-10 Volume:9 Page:928-937
ISSN:1862-8346
Container-title:PROTEOMICS - Clinical Applications
language:en
Short-container-title:Prot. Clin. Appl.

Author:

Baldelli Elisa¹²,Haura Eric B.³,Crinò Lucio²,Cress Douglas W.³,Ludovini Vienna²,Schabath Matthew B.³,Liotta Lance A.¹,Petricoin Emanuel F.¹,Pierobon Mariaelena¹

Affiliation:

1. Center for Applied Proteomics and Molecular Medicine; George Mason University; Manassas VA USA

2. Medical Oncology Division; S. Maria della Misericordia Hospital; Perugia Italy

3. Department of Thoracic Oncology; H. Lee Moffitt Cancer Center and Research Institute; Tampa FL USA

Funder

Istituto Superiore di Sanità

Italian Association for Cancer Research

Publisher

Wiley

Subject

Clinical Biochemistry

Reference34 articles.

1. Cancer statistics, 2014;Siegel;CA Cancer J. Clin,2014

2. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N. Engl. J. Med,2004

3. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy;Paez;Science,2004

4. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer;Kwak;N. Engl. J. Med,2010

5. Crizotinib versus chemotherapy in advanced ALK-positive lung cancer;Shaw;N. Engl. J. Med,2013

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative proteomic analysis of HER2 protein expression in PDAC tumors;Clinical Proteomics;2024-03-20

2. Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery;Clinical Cancer Research;2024-01-12

3. Protein signaling and drug target activation signatures to guide therapy prioritization: Therapeutic resistance and sensitivity in the I-SPY 2 Trial;Cell Reports Medicine;2023-12

4. AKT/mTOR signaling modulates resistance to endocrine therapy and CDK4/6 inhibition in metastatic breast cancers;npj Precision Oncology;2023-02-16

5. Analysis of neuroendocrine clones in NSCLCs using an immuno-guided laser-capture microdissection-based approach;Cell Reports Methods;2022-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3